Your browser doesn't support javascript.
loading
Association between dipeptidyl peptidase-4 inhibitors and increased risk for bullous pemphigoid within 3 months from first use: A 5-year population-based cohort study using the Japanese National Database.
Kuwata, Hirohito; Nishioka, Yuichi; Noda, Tatsuya; Kubo, Shinichiro; Myojin, Tomoya; Higashino, Tsuneyuki; Takahashi, Yutaka; Ishii, Hitoshi; Imamura, Tomoaki.
Afiliação
  • Kuwata H; Department of Diabetes and Endocrinology, Nara Medical University, Kashihara, Japan.
  • Nishioka Y; Department of Diabetes and Endocrinology, Nara Medical University, Kashihara, Japan.
  • Noda T; Department of Public health, Health Management and Policy, Nara Medical University, Kashihara, Japan.
  • Kubo S; Department of Public health, Health Management and Policy, Nara Medical University, Kashihara, Japan.
  • Myojin T; Department of Public health, Health Management and Policy, Nara Medical University, Kashihara, Japan.
  • Higashino T; Department of Public health, Health Management and Policy, Nara Medical University, Kashihara, Japan.
  • Takahashi Y; Healthcare and Wellness Division, Mitsubishi Research Institute, Tokyo, Japan.
  • Ishii H; Department of Diabetes and Endocrinology, Nara Medical University, Kashihara, Japan.
  • Imamura T; Department of Doctor-Patient Relationships, Nara Medical University, Kashihara, Japan.
J Diabetes Investig ; 13(3): 460-467, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34559464

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Penfigoide Bolhoso / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Diabetes Investig Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Penfigoide Bolhoso / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Diabetes Investig Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão